Anti-IL5 and anti-IL5R-alpha Therapy in Patients with clinically significant Bronchiectasis and an eosinophilic Endotype: a retrospective Case Series

被引：0
|
作者：
Rademacher, J. [1 ]
Konwert, S. [1 ]
Fuge, J. [1 ]
Dettmer, S. [2 ]
Welte, T. [1 ]
Ringshausen, F. C. [1 ]
机构：
[1] Hannover Med Sch, Klin Pneumol, Hannover, Germany
[2] Hannover Med Sch, Inst Radiol, Inst Diagnost & Intervent Radiol, Hannover, Germany
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
FV225
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [11] Long-term effectiveness of anti-IL4R therapy following suboptimal response to anti-IL5/5R therapy in severe eosinophilic asthma
    Gates, J.
    Fernandes, M.
    Hearn, A.
    Green, L.
    Thomson, L.
    Roxas, C.
    Lam, J.
    d'Ancona, G.
    Nanzer, A. M.
    Dhariwal, J.
    Jackson, D. J.
    THORAX, 2023, 78 (SUPPL_4) : A47 - A48
  • [12] Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Payne, Victoria
    Hearn, Andrew
    Kent, Brian D.
    D'Ancona, Grainne
    Dhairwal, Jaideep
    Nanzer, Alexandra M.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [13] Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis
    Ramonell, Richard P.
    Iftikhar, Imran H.
    LUNG, 2020, 198 (01) : 95 - 103
  • [14] Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis
    Richard P. Ramonell
    Imran H. Iftikhar
    Lung, 2020, 198 : 95 - 103
  • [15] Clinical Predictors of Treatment Failure to Anti-IL5 Therapy in Severe Eosinophilic Asthma
    Reihman, A. E.
    Liu, C.
    Cruse, M. H.
    Freid, L.
    Perez, N.
    Smith, V. L.
    Ferguson, L.
    Wechsler, M.
    Holguin, F.
    Manka, L.
    Sharma, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [16] A Late, Unusual Presentation of Chronic Eosinophilic Pneumonia Requiring Anti-IL5 Therapy
    Deng, X.
    Jung, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [17] Mepolizumab (Anti-IL5) and Exacerbation Frequency in Refractory Eosinophilic Asthma
    Haldar, P.
    Brightling, C.
    Hargadon, B.
    Gupta, S.
    Monteiro, W.
    Sousa, A.
    Marshall, R.
    Bradding, P.
    Green, R.
    Wardlaw, A.
    Pavord, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [18] Anti-IL5 /Rituximab Therapy for Patients suffering from therapy-refractory Eosinophilic Granulomatosis with Polyangiitis
    Gysan, Maximilian Robert
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 601 - 601
  • [19] The impact of anti-IL5 therapies on patients with severe eosinophilic asthma: a proteomic approach
    Cameli, P.
    Vantaggiato, L.
    D'Alessandro, M.
    Bergantini, L.
    Shaba, E.
    Carleo, A.
    Di Giuseppe, F.
    Angelucci, S.
    Bini, L.
    Bargagli, E.
    Landi, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [20] Heterogeneous ILC responses in severe asthma patients undergoing anti-IL5/5Rα therapy
    Mincham, Kyle
    Loewenthal, Lola
    Meyer, Garance
    Marfia, Martina
    Martin, Minerva Garcia
    Patel, Pujan
    Lloyd, Clare
    Snelgrove, Robert
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 19 - 19
12345